Welcome to the Frankfurt Foundation Quality of Medicines

Every day, medicinal products make a decisive contribution to prevent diseases – especially serious ones – or alleviating ailments, extending the life expectancy of patients and improving their quality of life. In addition to our high expectations of the efficacy and safety of medicines, the pharmaceutical quality of the products is also particularly important with regard to patient care.

The Frankfurt Foundation Quality of Medicines (FFQM) is committed to promoting research activities that are designated to optimally assure the quality of medicinal products in Germany and Europe or, if necessary, further improving them, especially if they are manufactured outside the country. Main concern is the development of advanced processes, the implementation of innovative technologies and their standardization as well as a critical verification of quality assurance concepts.

Download the FFQM flyer here (PDF-File, ~200kB)

News

March 11, 2022

Quality of Medicines Award announced

The Frankfurt Foundation Quality of Medicines (FFQM) and the German Pharmaceutical Society (DPhG) jointly award the the Quality of Medicines prize 2022 for outstanding scientific achievements in the field of optimizing and ensuring the quality of drugs.

We would like to support fundamental investigations into the quality of drugs on the market as well as innovative concepts to improve them.

Applications can be submitted electronically to the Frankfurt Foundation Quality of Medicines (info@frankfurt-foundation.org) until July 15, 2022.

Read more

November 13, 2021

Lifetime Achievement Award of the foundation: Professor Emeritus Dr. Josè Morais, University Lisbon awarded

In a ceremony on November 13, 2021, the Frankfurt Foundation Quality of Medicines (FFQM) awarded the „Lifetime Achievement Award“ for the first time for exceptional scientific contributions to the optimization of drug quality. With this prize, the special merits of the award winner Professor Emeritus Dr. Josè Augusto Guimarães Morais, University of Lisbon, were recognized for the development of regulatory criteria for the comparative assessment of the bioavailability of systemic drugs. As a member of the European Approval Commission CPMP/CHMP and chairman of an EU expert group, Professor Morais made significant contributions to the introduction of guidelines on bioavailability and bioequivalence at EU level. „We are very pleased that we can award the prize to such an outstanding scientist,“ explains the founder and chairman of the foundation, Professor Dr. Henning Blume, who has been committed to promoting drug quality himself for many years.

Read more

October 1, 2021

Dr. Oliver Scherf-Clavel received the "Quality of Medicines Award"

The „Preis zur Förderung der Arzneimittelqualität“ was awarded for the first time in October. The award winner is junior professor Dr. Oliver Scherf-Clavel.

Read more

Kreis
zum Seitenanfang
Q